Dr. Reddys Laboratories informs about press release

11 Aug 2020 Evaluate

Dr. Reddys Laboratories has informed that it has enclosed a Press Release on 11th August   2020 ‘Dr. Reddy's Laboratories announces the First-to Market launch of the generic version of Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1151.95 -14.95 (-1.28%)
21-Jan-2026 10:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 1151.95
Cipla 1369.05
Zydus Lifesciences 873.80
Lupin 2170.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×